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THE effects on the incidence of spontaneous mammary carcinoma of breeding
and of age in C3Hf mice have been recorded (Pullinger and Iversen, 1960). None
of the tests done to detect the mammary tumour agent disclosed its presence in
this strain (Pullinger, 1960a). A reduction in mammary tumour incidence in
former breeding females after ovariectomy alone was reported (Pullinger, 1960b).
In the present paper the incidence of mammary carcinoma and adenoma in
C3Hf breeders after late ovariectomy with subsequent treatment with oestrone is
described.
MATERIALS AND METHODS
Surplus breeders of generations F5 to F16 of the pure line C3Hf colony were
ovariectomised at the age of 9 to 11 months. The operation and subsequent
management were the same as that recorded for ovariectomy alone (Pullinger,
1960b) except that the animals were treated thereafter with oestrone once weekly
for 30 weeks. One experimental group comprising 30 animals received 5 ,tg.
weekly, the other of 23 received 10 ,ug. weekly. The oestrone was dissolved in
acetone (0-01 per cent) and applied to the whole area of the clipped backs in
measured doses of 0 05 and 0.1 ml. respectively. The treated animals were
allowed to live out their lives and were killed only when they had developed
tumours or were about to die. At necropsy the operation sites were examined to
ascertain that no ovarian fragments remained. Adrenal glands, tumours and
nipple regions from samples of mice from both groups were fixed for histological
examination. All 10 nipple regions from samples of mammae were bulk-stained
to count adenomas. The samples were selected throughout the experimental
period according to the state of preservation of the cadavers and sometimes to
time available for microdissection. In specimens where the degree of involution
did not allow certainty in count, or where a mammary carcinoma had overgrown
most of the nipple region, accurate counts were not possible and were not
attempted. Two of the carcinomas were grafted into C3Hf hosts.
RESULTS
5 ,ag. oestrone weekly
In this group 2 out of the 30 animals (- 6-6 per cent) developed mammary
carcinoma. Both tumours were of type B (Dunn, 1959). One of the tumour-
bearing animals died after having received a total dose of 85 jug. of oestrone (outB. D. PULLINGER
of 150jpg. possible) and one non-tumour animal died after a total dose of 110 ,tg.
oestrone (Tables I and II).
TABLE I.-Mammary Carcinoma Incidence after Ovariectomy and Substituted
Oestrone in C3Hf Former Breeders and Numbers ofLitters
Ovariectomised breeders
5,ug. Oestrone 10pg. Oestrone
Number of Number of Number with Number of Number with
Litters Females Carcinoma Females Carcinoma
2
3
4
5
6
7
8
9
Totals
Per cent
0
0
19
8
2
0
0
1
0
30
0
0
0
2
0
0
0
0
0
2
6 6
1
2
4
5
4
1
3
2
1
23
0
1
1
2
0
0
1
1
0
6
26
TABLE II.-Mammary Carcinoma Incidence in Former C3Hf Breeders after
Ovariectomy and Substituted Oestrone with Survival Ages
Ovariectomised breeders
{ _ -A ---
5pg. Oestrone
Number of Number with
Females Carcinoma
0 0
0 0
0 0
1 0
1 1
0 0
0 0
2 0
1 0
0 0
1 0
1 0
3 0
1 U
0 0
5 0
6 0
3 0
1 0
3 0
1 1
30 2
6-6
10 g. Oestrone
A.
Number of Number with
Females Carcinoma
0 0
0
0
2
0
0
1
2
4
2
0
2
1
3
2
0
0
23
0
0
0
0
0
0
0
2
1
1
0
1
0
0
0
0
0
0
6
26
Eighteen mammary glands were examined by bulk-staining and of these 12
bore adenomas and the total number of adenomas was 87 (Table III). The
Age at death,
in months
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
Totals
Per Cent
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findings at necropsy were: 6 with hepatoma; 2 with lung adenoma; one hae-
mangio-endothelioma; 5 overt lymphomas; 3 squamous carcinomas; 1 with
several bladder calculi which did not cause apparent symptoms.
TABLE III. Adenomatous Nodule Incidence after Ovariectomy and Substituted
Oestrone in C3Hf Breeder8
Number of Number Percentage Average
mice with with Total Number per
examined Nodules Nodules Nodules Mouse
Ovariectomy only 25 11 44 33 3
Oestrone 5jug. 18 12 66-6 87 7-2
Oestrone 10lug. 14 14 100 239 17-0
Eighteen pairs of adrenal glands were examined microscopically. Type A and
compact fasciculata cells were present in 11 and B cells in 15, in two of which
the cells were hyperplastic. There were no cortical carcinomas. Two medullary
carcinomas were found in 2 mice and 2 others had each one accessory adrenal
gland. The latter were composed of compact fasciculata cells. Adrenal cell
nomenclature is in accordance with that of Woolley and Little (1945). Compact
cells of the zona fasciculata in C3Hf mlice were described previously (Pullinger,
1959).
10 Itg. oestrone wueekly
In this group 6 out of 23 (26 per cent) developed mammary carcinoma. Two
tumours were oftype A, one oftype B, 2 oftype C and 1 was an adenoacanthoma.
Out of a possible total of 300 ,ug., one female which developed a mammary carci-
noma received 50 lig. Two others without carcinoma had 190 and 200 ,g.
respectively. Of 14 samples of mammarygland, 14 bore adenomas and the total
number of adenomas was 239 (Tables I, II and III). Of 22 females that lived to
16 months or more 3 had hepatoma. One mouse had an osteogenic sarconma of
the tail which was excised but metastasised to the lungs. Four of the 23 were
found at necropsy to have urinary calculi. None of the calculi had caused
hydro- or pyonephrosis nor death. None of these 4 had mammary carcinoma.
No pituitary enlargements were found in either experiment.
Grafts from 2 mammary carcinomas grew in totals of 5 out of 5 females and
in 5 out of 6 males.
Survival data and numbers of litters for ovariectomy only and for the 2
experiments here recorded are given in Fig. 1 and 2. Fertility in the group given
5 ,tg. oestrone weekly was slightly inferior to that given 10 ,ag. The impression
was gained that breeding capacity was lessened or delayed by separation ofgroups
of females after weaning before being mated. Groups were used for 5 ,ag. but
for 10 tlg. the females remained from birth with their brothers.
DISCUSSION
Treatment per cutem was preferred to multiple subcutaneous injections of
oestrone in oil. According to Emmens (1950) either method is valid for assay
purposes. In assays of dose-responses in RlIIf mammary glands absorption by
this route -was found to occur (Iversen, 1957). Application through the skinB. D. PULLINGER
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FIG. 1.-Represents the cumulative percentage of breeders and number of litters.
x = Breeders ovariectomised only.
* Breeders ovariectomised and given 5jug. oestrone weekly.
O = Breeders ovariectomised and given 10p,g. oestrone weekly.
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FIG. 2.-Represents the cumulative percentage of survivors and age in months.
x = Bree~ders ovariectomised only. -
0= Breeders ovariectomised and given 5pug. oestrone we-ekly.
o = Breeders ovariectomised and given 10pug. oestrone weekly.
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avoids possible spoiling of nipple regions that are to be used for adenomatous
nodule counts.
Previous attempts to test the oestrone dose and tumour response in RIIIf
breeders and virgins (Pullinger, 1955, 1957) had been made with measured dosage
per mouse and this method was preferred. In the experiments of Boot and
Muhlbock (1956) two levels of oestrone of 125 lag. and 2000 pg. per litre were
maintained in the drinking water of C3Hf and C3He virgin females. Both sub-
strains have the same genetic constitution by derivation as the one used here.
Tumour incidence in intact and in mice ovariectomised at 150 to 250 days (Fig. 8)
maintained under these dose levels did not differ materially. It was greater at
the higher dose level and reached an incidence characteristic for breeders of these
strains.
Urinary calculi of ammonium, calcium and magnesium phosphates were found
in 4 out of our 23 former breeding females, ovariectomised and given 10 ,tg. of
oestrone weekly but none had caused any deaths. In 108 intact breeders of the
ieference group (Pullinger and Iversen, 1960) no breeders with urinary calculi
had been seen. No higher dose level of oestrone was tested on account of these
observations and because experience with post-pubertal females indicated that,
for the same reason, 10pg. weekly is outside physiological limits for this oestrogen.
Previously, Schenken, Burns and McCord (1942) reported the incidence of urinary
calculi in untreated intact and in intact C3H males and females treated with
c-oestradiol benzoate. In males the incidence of calculi was increased after
treatment but not in females. This discrepancy between results in C3H and
C3Hf females could be due to earlier deaths of the C3H from mammary carcinoma
associated with the mammary tumour agent.
Observations and experiments thus far concluded indicate that the breeding
factor increased the number of females with mammary carcinoma from 2 per
cent in non-breeders to 25 per cent and adenoma from 29 per cent in non-breeders
to 80 per cent. When ovaries were removed after an adequate breeding stimulus,
as measured by the number of litters born prior to ovariectomy, carcinoma
incidence was reduced to that of non-breeders, or if the one tumour bearer that
had an adrenal cortical carcinoma with evidence ofoestrogen secretion is excluded,
to nil. Females with adenomatous nodules fell from 84 per cent among those in
the reference group which had borne roughly comparable numbers of litters to
44 per cent after late ovariectomy. When oestrone near in amount to the limit
of tolerance was substituted after ovariectomy, the-incidence of spontaneous
carcinoma that can be expected for intact breeders was realised. Adenoma
incidence reached 100 per cent. These findings show that breeding determined
the potentiality for a greater incidence of tumours than in non-breeders but that
continued high-level exposure to oestrone in later life was necessary to realise this
potentiality. The actual incidence was related quantitatively to the dose level
of oestrone. Whether oestrone alone or in combination with other oestrogens is
able in virgin females to replace the breeding factor is being tested. The results
of Boot and Muhlbock (1956) showed that oestrone alone is effective and our
figures to date support such a conclusion. Whether or not oestrone similarly
applied after late ovariectomy of non-breeders would be effective in realising as
high an incidence as in former breeders requires to be tested by continued high
level dosage for the same period of their lives. The answer, if affirmative, might
supply a clue to the incidence in human nulliparous females. The incidence in132 B. D. PULLINGER
the latter is generally considered to be even higher than in multiparae. Does
oestrogen secretion continue at a high level during the climacteric ? Identity of
human and mouse oestrogens is not assumed, merely similarity ofaction, mediated
through the pituitary gland, on mammary epithelium.
The existence ornot in this strain ofsmall residual amounts ofmammary tumour
agent perhaps remains disputable. The recent publication ofvery high magnifica-
tions of 130,000 to 360,000 times of the agent stained in situ with lead hydroxide
by Bernard (1960) makes possible the identification of individual and possibly
unique particles of the mammary tumour agent. The problem of explaining
discrepancies between negative biological tests and the presence of morphological
images of the mammary tumour agent is discussed by Bernard. Continued
breeding and observation of this C3Hf strain and experience of substituted oestro-
gen in post-pubertal females and breeders has failed to provide evidence of the
presence of the agent. It is considered that mammary tumours of this C3Hf
strain are due to a heritable tendency and that their development and actual
incidence depend upon the level of oestrogen of their hormonal environment,
especially in later life.
SUMMARY
Two out of 30 C3Hf breeders ovariectomised at 10 to 11 months of age and
subsequently treated with 5 ,ug. oestrone weekly developed mammary carcinoma;
12 out of the 18 examined bore adenomatous nodules.
Six out of 23 breeders similarly ovariectomised but treated with 10jIg. oestrone
weekly developed mammary carcinoma; 14 out of 14 bore adenomatous nodules.
Continued high level exposure to oestrone after breeding and ovariectomy brought
the incidence from 2 per cent, found after ovariectomy only, to 26 per cent which
is the spontaneous incidence for breeders of this strain.
I am indebted to Dr. S. Iversen for Fig. 1 and 2.
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